Copyright © 1990 by the European Society of Cardiology.
© 1990 The European Society of Cardiology
Relative survival of patients after heart valve replacement
*Medical Department B, Rikshospitalet, University of Oslo Oslo,Norway
Institute of Medical Statistics,Ulleval Hospital, Oslo Oslo,Norway
Institute of Epidemiological Cancer Research, The Radium Hospital Oslo, Norway
Received 20 March 1989; revised 16 June 1989; .
correspondence: Sigurd Nitter-Hauge M.D., Professor in Cardiology, Medical Department B. Laboratory of Cardiology, Rikshospitalet, 0027 Oslo 2, Norway
Abstract
Long-term results after prosthetic heart valve replacement are usually presented in actuarial terms, which do not take into account the background mortality of the general population. The calculations of the relative survival, which is the ratio between the observed survival in a group of patients during a specified time interval and the survival expected from the general population experience, permit correction for important demographic variables. We have analysed the long-term relative survival rates in a consecutive series of 841 Norwegian patients who, on the basis of clinical symptoms, underwent aortic (A VR,n = 617), mitral (MVR, n = 146), and double (A VR + MVR, n = 78) valve replacement between June 1977 and January 1985. The follow-up was closed on May 1st 1986, was 100% complete and included 2056 patient-years. The actuarial survival data for the total cohort was 75-1%, and for AVR, MVR and DVR, 77–9, 69–7 and 63-0%, respectively. The corresponding figures for the relative survival were 83–5,87–0, 76–6 and69l%, respectively. Within the subgroup undergoing A VR, our analysis demonstrated a poor prognosis in those who were operated for pure aortic regurgitation or endocarditis, as well as in those who received the smallest valve size prosthesis due to a narrow aortic root. In this analysis, as in the analysis of the total material, we observed that the differences between survival in the patients and in the general population were of smaller magnitude when based on relative survival rates than when analysed in the standard (actuarial) way.Patients aged 
30 years who underwent AVR achieved a normalized survival pattern for the total observation period. Patients aged > 70 years had a normalized survival pattern for the first three postoperative years, which could be partly explained by pre-operative patient selection.
Key Words: Heart valve replacement • observed survival • relative survival
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. H. Blackstone, D. M. Cosgrove, W.R. E. Jamieson, N. J. Birkmeyer, J. H. Lemmer Jr, D. C. Miller, E. G. Butchart, G. Rizzoli, M. Yacoub, and A. Chai Prosthesis size and long-term survival after aortic valve replacement J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 783 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Babin-Ebell, C. Schuster, O. Elert, R. Bergemann, D. Horstkotte, and GELIA Study Group Influence of valve size on morbidity and mortality for patients with mechanical valve replacements (GELIA 8) Eur. Heart J. Suppl., December 1, 2001; 3(suppl_Q): Q73 - Q77. [Abstract] [PDF]
|
|
|
|
|
|
O. Bech-Hanssen, K. Caidahl, I. Wallentin, P. Ask, and B. Wranne Assessment of effective orifice area of prosthetic aortic valves with Doppler echocardiography: An in vivo and in vitro study J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 287 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J.O. Birkmeyer, J. D. Birkmeyer, A. N.A. Tosteson, G. L. Grunkemeier, C. A.S. Marrin, and G. T. O'Connor Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis Ann. Thorac. Surg., December 1, 2000; 70(6): 1946 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kvidal, R. Bergstrom, L.-G. Horte, and E. Stahle Observed and relative survival after aortic valve replacement J. Am. Coll. Cardiol., March 1, 2000; 35(3): 747 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Kuhn, U. Muller-Werdan, D.V. Schmitt, H. Lange, G. Pilz, E. Kreuzer, F.W. Mohr, H.-R. Zerkowski, and K. Werdan Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988-1990: the ESSICS-study pilot project Eur. J. Cardiothorac. Surg., January 1, 2000; 17(1): 30 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Bech-Hanssen, K. Caidahl, B. Wall, P. Myken, S. Larsson, and I. Wallentin INFLUENCE OF AORTIC VALVE REPLACEMENT, PROSTHESIS TYPE, AND SIZEON FUNCTIONAL OUTCOME AND VENTRICULAR MASS IN PATIENTS WITH AORTIC STENOSIS J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Rosen, V. G. Fowler Jr., G. R. Corey, S. M. Downs, A. K. Biddle, J. Li, and J. G. Jollis Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia Ann Intern Med, May 18, 1999; 130(10): 810 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Fiane, O. R. Geiran, and J. L. Svennevig Up to eight years' follow-up of 997 patients receiving the CarboMedics prosthetic heart valve Ann. Thorac. Surg., August 1, 1998; 66(2): 443 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Bolling, G. M. Deeb, L. A. Brunsting, and D. S. Bach Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy J. Thorac. Cardiovasc. Surg., April 1, 1995; 109(4): 676 - 683. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. F. Mitchel, D. B. Fram, D. F. Palme II, R. Foster, J. A. Hirst, M. A. Azrin, L. M. Bow, A. M. Eldin, D. D. Waters, and R. G. McKay Enhanced Intracoronary Thrombolysis With Urokinase Using a Novel, Local Drug Delivery System : In Vitro, In Vivo, and Clinical Studies Circulation, February 1, 1995; 91(3): 785 - 793. [Abstract] [Full Text]
|
|